Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Haematoma, Incorrect route of product administration, Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: When they got their shot the person was not good at giving it and they shot a blood; hemotoa apparently caused by person injucting; Rash, upper arm swelling to elbow with rash; huge area that was hard; huge area that was red; huge area that was very painful; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (When they got their shot the person was not good at giving it and they shot a blood), HAEMATOMA (hemotoa apparently caused by person injucting), RASH (Rash, upper arm swelling to elbow with rash), INJECTION SITE INDURATION (huge area that was hard) and INJECTION SITE ERYTHEMA (huge area that was red) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Pollen allergy. Concomitant products included RIZATRIPTAN BENZOATE (MAXALT) from 01-Jun-1985 to an unknown date for Migraine, LEVOTHYROXINE SODIUM (LEVOXYL) from 03-Jun-2000 to an unknown date, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) from 01-Jun-2017 to an unknown date, MAGNESIUM, BOTULINUM TOXIN TYPE A (BOTOX) and DENOSUMAB (PROLIA) from 01-Jun-2017 to an unknown date for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced INJECTION SITE INDURATION (huge area that was hard), INJECTION SITE ERYTHEMA (huge area that was red) and INJECTION SITE PAIN (huge area that was very painful). On an unknown date, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (When they got their shot the person was not good at giving it and they shot a blood), HAEMATOMA (hemotoa apparently caused by person injucting) and RASH (Rash, upper arm swelling to elbow with rash). On 15-Feb-2021, INJECTION SITE INDURATION (huge area that was hard) and INJECTION SITE ERYTHEMA (huge area that was red) had resolved. At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (When they got their shot the person was not good at giving it and they shot a blood), HAEMATOMA (hemotoa apparently caused by person injucting) and RASH (Rash, upper arm swelling to elbow with rash) had resolved and INJECTION SITE PAIN (huge area that was very painful) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-096853, MOD-2021-096933, MOD-2021-096853 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Additional info